EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Impact of Clopidogrel Treatment on Timing of Coronary Artery Bypass Graft Surgery

Tom Friedman, Elad Yosef, Ela L. A. Walling, Maged Makhoul, Roi Glam, Moshe David Campisi Pinto, Gil Bolotin

Journal of Cardiac Surgery · 2026-01 · 2026 (1)

DOI: 10.1155/jocs/6619958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiac Surgery, online erschienen am 08.05.2026. Verfasst von Tom Friedman und 6 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Current guidelines advise stopping clopidogrel at least 5 days prior to coronary artery bypass grafting (CABG) in patients with acute coronary syndrome to lower bleeding risk. However, this delay may increase the risk of cardiovascular events. This study evaluated the impact of clopidogrel discontinuation timing on bleeding and postoperative outcomes.

Methods

This retrospective single‐center study analyzed data from 472 patients treated with clopidogrel who underwent CABG. Patients were grouped based on the duration between clopidogrel cessation and surgery: 1–2 days ( n = 42), 3–4 days ( n = 89), and ≥ 5 days ( n = 341). Outcomes included bleeding complications and transfusion requirements.

Results

No significant difference was found in clinically substantial bleeding (defined as chest tube drainage > 800 mL within 12 h postsurgery) among the groups ( p = 0.45). However, earlier surgery was associated with greater transfusion requirements. Patients operated on within 1–2 days had 2.52 times higher odds of requiring blood product transfusion (95% CI: 1.32–4.83), and those at 3–4 days had 1.69 times higher odds (95% CI: 1.05–2.71), compared to those with ≥ 5 days.

Conclusions

In this single‐center cohort, a waiting period of at least 5 days between clopidogrel cessation and CABG was associated with lower transfusion requirements, without a clear increase in early clinically substantial bleeding, thereby supporting current guideline recommendations for stable patients.

Zitieren

APA

Friedman, T., Yosef, E., Walling, E. L. A., Makhoul, M., Glam, R., Pinto, M. D. C., & Bolotin, G. (2026). Impact of Clopidogrel Treatment on Timing of Coronary Artery Bypass Graft Surgery. Journal of Cardiac Surgery, 2026(1). https://doi.org/10.1155/jocs/6619958

Vancouver

Friedman T, Yosef E, Walling ELA, Makhoul M, Glam R, Pinto MDC, et al. Impact of Clopidogrel Treatment on Timing of Coronary Artery Bypass Graft Surgery. Journal of Cardiac Surgery. 2026;2026(1). doi:10.1155/jocs/6619958

BibTeX
@article{Friedman2026,
  author = {Friedman, Tom and Yosef, Elad and Walling, Ela L. A. and Makhoul, Maged and Glam, Roi and Pinto, Moshe David Campisi and Bolotin, Gil},
  title = {Impact of Clopidogrel Treatment on Timing of Coronary Artery Bypass Graft Surgery},
  journal = {Journal of Cardiac Surgery},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jocs/6619958}
}
Kostenlos starten →